JP2000508662A5 - - Google Patents

Download PDF

Info

Publication number
JP2000508662A5
JP2000508662A5 JP1997537456A JP53745697A JP2000508662A5 JP 2000508662 A5 JP2000508662 A5 JP 2000508662A5 JP 1997537456 A JP1997537456 A JP 1997537456A JP 53745697 A JP53745697 A JP 53745697A JP 2000508662 A5 JP2000508662 A5 JP 2000508662A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997537456A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000508662A (ja
JP4121151B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1997/007070 external-priority patent/WO1997038999A1/en
Publication of JP2000508662A publication Critical patent/JP2000508662A/ja
Publication of JP2000508662A5 publication Critical patent/JP2000508662A5/ja
Application granted granted Critical
Publication of JP4121151B2 publication Critical patent/JP4121151B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP53745697A 1996-04-12 1997-04-09 抗新生物薬および抗レトロウイルス薬として有用なアクリドンから誘導された化合物 Expired - Fee Related JP4121151B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US1532696P 1996-04-12 1996-04-12
US60/015,326 1996-04-12
US3505097P 1997-01-22 1997-01-22
US60/035,050 1997-01-22
PCT/US1997/007070 WO1997038999A1 (en) 1996-04-12 1997-04-09 Acridone-derived compounds useful as antineoplastic and antiretroviral agents

Publications (3)

Publication Number Publication Date
JP2000508662A JP2000508662A (ja) 2000-07-11
JP2000508662A5 true JP2000508662A5 (enExample) 2004-10-28
JP4121151B2 JP4121151B2 (ja) 2008-07-23

Family

ID=26687242

Family Applications (1)

Application Number Title Priority Date Filing Date
JP53745697A Expired - Fee Related JP4121151B2 (ja) 1996-04-12 1997-04-09 抗新生物薬および抗レトロウイルス薬として有用なアクリドンから誘導された化合物

Country Status (10)

Country Link
US (2) US6187775B1 (enExample)
EP (1) EP0892801B1 (enExample)
JP (1) JP4121151B2 (enExample)
AT (1) ATE211471T1 (enExample)
AU (1) AU725629B2 (enExample)
DE (1) DE69709857T2 (enExample)
DK (1) DK0892801T3 (enExample)
ES (1) ES2171260T3 (enExample)
PT (1) PT892801E (enExample)
WO (1) WO1997038999A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1293525B1 (it) * 1997-08-01 1999-03-01 Uni Degli Studi Camerino Bis-acridincarbossiammidi aventi attivita' antitumorale
WO2001066545A2 (en) * 2000-03-07 2001-09-13 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services 1,8-NAPHTHALIMIDE IMIDAZO[4,5,1-de]ACRIDONES WITH ANTI-TUMOR ACTIVITY
US7144843B2 (en) * 2001-01-31 2006-12-05 Meiji Seika Kaisha, Ltd. Pest controllers
US6670071B2 (en) * 2002-01-15 2003-12-30 Quallion Llc Electric storage battery construction and method of manufacture
CA2470365C (en) 2002-11-20 2011-05-17 Japan Tobacco Inc. 4-oxoquinoline compound and use thereof as hiv integrase inhibitor
RU2275361C3 (ru) * 2002-11-20 2021-10-01 Джапан Тобакко Инк. Соединение 4-оксохинолина и его применение в качестве ингибитора вич интегразы
US8512144B2 (en) * 2003-10-20 2013-08-20 Tipping Point Group, Llc Method and apparatus for providing secondary gaming machine functionality
MY134672A (en) 2004-05-20 2007-12-31 Japan Tobacco Inc Stable crystal of 4-oxoquinoline compound
WO2005113509A1 (en) 2004-05-20 2005-12-01 Japan Tobacco Inc. Novel 4-oxoquinoline compound and use thereof as hiv integrase inhibitor
ATE518866T1 (de) * 2004-06-30 2011-08-15 Council Scient Ind Res Über die piperazineinheit gebundene pyrroloä2,1- cüä1,4übenzodiazepin-napthalimid-konjugate und verfahren zu deren herstellung
US8377586B2 (en) * 2005-10-05 2013-02-19 California Institute Of Technology Fluoride ion electrochemical cell
US7829578B1 (en) 2005-12-12 2010-11-09 Oregon Health & Science University Aromatic ketones and uses thereof
WO2007092436A2 (en) * 2006-02-08 2007-08-16 Xanthus Pharmaceuticals, Inc. Compounds for treating inflammatory disorders, demyelinating disorders and cancers
IN2014CN00613A (enExample) 2006-03-06 2015-08-21 Japan Tobacco Inc
WO2007136858A2 (en) 2006-05-19 2007-11-29 H. Lee Moffitt Cancer Center & Research Institute Small molecule inhibitors of stat3 with anti-tumor activity
WO2008016661A2 (en) * 2006-08-02 2008-02-07 Xanthus Pharmaceuticals, Inc. Morpholino compounds for treating inflammatory and demyelinating diseases and cancers
AU2007316416A1 (en) * 2006-11-07 2008-05-15 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Self-assembling nanoparticles composed of transmembrane peptides and their application for specific intra-tumor delivery of anti-cancer drugs
WO2008064011A1 (en) 2006-11-13 2008-05-29 The Government Of The U.S. Of America As Represented By The Department Of Veterans Affairs Acridone compounds
US8598354B2 (en) 2008-12-05 2013-12-03 University Of South Florida Compounds having antiparasitic or anti-infectious activity
PL3070078T3 (pl) * 2015-03-20 2018-02-28 Politechnika Gdańska Niesymetryczne bisakrydyny o działaniu przeciwnowotworowym i ich zastosowania

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9104548D0 (en) * 1991-03-05 1991-04-17 Cholody Wienlaw M Antineoplastic modified imidazoacridines
US5508289A (en) * 1994-03-14 1996-04-16 The United States America As Represented By The Department Of Health And Human Services Bis-acridone chemotherapeutic derivatives

Similar Documents

Publication Publication Date Title
JP2000502280A5 (enExample)
JP2000501771A5 (enExample)
JP2000510980A5 (enExample)
JP2000501599A5 (enExample)
JP2001506876A5 (enExample)
JP2000501018A5 (enExample)
JP2000501324A5 (enExample)
JP2001507963A5 (enExample)
JP2000502472A5 (enExample)
JP2000501825A5 (enExample)
JP2000501338A5 (enExample)
JP2000514136A5 (enExample)
JP2000500874A5 (enExample)
JP2001526715A5 (enExample)
JP2000502485A5 (enExample)
JP2000502425A5 (enExample)
JP2000502568A5 (enExample)
JP2000501774A5 (enExample)
JP2000500912A5 (enExample)
JP2000502570A5 (enExample)
JP2000514672A5 (enExample)
JP2000501876A5 (enExample)
JP2001500552A5 (enExample)
JP2000501744A5 (enExample)
JP2000501229A5 (enExample)